High aldehyde dehydrogenase activity at diagnosis predicts relapse in patients with t(8;21) acute myeloid leukemia

Acute myeloid leukemia (AML) with t(8;21) is a heterogeneous disease. Although the detection of minimal residual disease (MRD), which is indicated by RUNX1‐RUNX1T1 transcript levels, plays a key role in directing treatment, risk stratification needs to be improved, and other markers need to be asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Lu, Chen, Wen‐Min, Dao, Feng‐Ting, Zhang, Yan‐Huan, Wang, Ya‐Zhe, Chang, Yan, Liu, Yan‐Rong, Jiang, Qian, Zhang, Xiao‐Hui, Liu, Kai‐Yan, Huang, Xiao‐Jun, Qin, Ya‐Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745853/
https://www.ncbi.nlm.nih.gov/pubmed/31364309
http://dx.doi.org/10.1002/cam4.2422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745853/
https://www.ncbi.nlm.nih.gov/pubmed/31364309
http://dx.doi.org/10.1002/cam4.2422

Ejemplares similares